Cargando…

Adjuvant chemotherapy and HER-2-directed therapy for early-stage breast cancer in the elderly

There is a lack of sufficient evidence-based data defining the optimal adjuvant systemic therapies in older women. Recommendations are mainly based on retrospective studies, subgroup analyses within larger randomised trials and expert opinion. Treatment decisions should consider the functional fitne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, J, Chia, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Minireview
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5220141/ https://www.ncbi.nlm.nih.gov/pubmed/27875517 http://dx.doi.org/10.1038/bjc.2016.360

Ejemplares similares

Targeting HER proteins in cancer therapy and the role of the non-target HER3
por: Hsieh, A C, et al.
Publicado: (2007)

Beyond trastuzumab: novel therapeutic strategies in HER2-positive metastatic breast cancer
por: Tsang, R Y, et al.
Publicado: (2012)

Low-dose immunotherapy as a potentiator to increase the response with neo-adjuvant chemotherapy in oral cancers
por: Rathinasamy, Narmadha, et al.
Publicado: (2023)

Adjuvant trastuzumab and vinorelbine for early-stage HER2+ breast cancer
por: McLaughlin, Shannon, et al.
Publicado: (2023)

HER2-positive advanced breast cancer: optimizing patient outcomes and opportunities for drug development
por: Singh, J C, et al.
Publicado: (2014)

Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy?
por: Langley, R E, et al.
Publicado: (2011)

Adjuvant therapy for lung neuroendocrine neoplasms
por: Ramirez, Robert A, et al.
Publicado: (2021)

Strategies to overcome trastuzumab resistance in HER2-overexpressing breast cancers: focus on new data from clinical trials
por: Lavaud, Pernelle, et al.
Publicado: (2014)

Postoperative adjuvant therapy for hepatocellular carcinoma with microvascular invasion
por: Li, Jiang, et al.
Publicado: (2023)

Adjuvant therapy of HER2(+ )breast cancer
por: Winer, EP
Publicado: (2009)

Advances in traditional Chinese medicine as adjuvant therapy for diabetic foot
por: Liu, Fa-Shun, et al.
Publicado: (2022)

Cost-utility analysis of adjuvant trastuzumab therapy for HER2-positive early-stage breast cancer in the Philippines
por: Genuino, Anne Julienne, et al.
Publicado: (2019)

Neoadjuvant endocrine therapy in primary breast cancer: indications and use as a research tool
por: Chia, Y H, et al.
Publicado: (2010)

Metronomic chemotherapy for non-metastatic triple negative breast cancer: Selection is the key
por: Rabanal, Connie, et al.
Publicado: (2017)

Early-onset colorectal cancer: Current insights and future directions
por: Wu, Claudia Wing-Kwan, et al.
Publicado: (2022)

De-escalation of adjuvant chemotherapy for HER2 negative breast cancer
por: Okines, Dr Alicia FC, et al.
Publicado: (2021)

Current status of the adjuvant therapy in uterine sarcoma: A literature review
por: Rizzo, Alessandro, et al.
Publicado: (2019)

Assessment of delayed bleeding after endoscopic submucosal dissection of early-stage gastrointestinal tumors in patients receiving direct oral anticoagulants
por: Sugimoto, Mitsushige, et al.
Publicado: (2023)

Management of early rectal cancer; current surgical options and future direction
por: Chavda, Vijay, et al.
Publicado: (2021)

Direct non-cyclooxygenase-2 targets of celecoxib and their potential relevance for cancer therapy
por: Schönthal, A H
Publicado: (2007)

Androgen deprivation therapy as adjuvant/neoadjuvant to radiotherapy for high-risk localised and locally advanced prostate cancer: recent developments
por: Payne, H, et al.
Publicado: (2011)

Dual HER2 inhibition strategies in the management of treatment-refractory metastatic colorectal cancer: History and status
por: Kanat, Ozkan, et al.
Publicado: (2018)

The treatment of early breast cancer in women over the age of 70
por: Ring, A, et al.
Publicado: (2011)

Adjuvant chemotherapy for early-stage cervical cancer
por: Asano, Hiroshi, et al.
Publicado: (2016)

Natural products for cancer chemotherapy
por: Demain, Arnold L., et al.
Publicado: (2011)

Exosomal miRNA in early-stage hepatocellular carcinoma
por: Wu, Zhi-Qiang, et al.
Publicado: (2023)

Adjuvant chemotherapy for early breast cancer.
por: Henderson, I. C.
Publicado: (1990)

Beta receptor blocker therapy for the elderly in the COVID-19 era
por: Santillo, Elpidio, et al.
Publicado: (2022)

Effect of different chemotherapy schemes on early-stage breast cancer patients with Low HER-2 expression
por: Xu, Yurui, et al.
Publicado: (2023)

Is there a role for chemotherapy in prostate cancer?
por: Canil, C M, et al.
Publicado: (2004)

Role of surgery for colorectal cancer in the elderly
por: Biondi, Antonio, et al.
Publicado: (2016)

Prognostic & predictive factors for planning adjuvant chemotherapy of early-stage breast cancer
por: Esbah, Onur, et al.
Publicado: (2017)

Patients' preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile?
por: Jansen, S J T, et al.
Publicado: (2001)

Prevention of hepatitis B reactivation in patients requiring chemotherapy and immunosuppressive therapy
por: Shih, Chih-An, et al.
Publicado: (2021)

New horizons for uncommon mutations in non-small cell lung cancer: BRAF, KRAS, RET, MET, NTRK, HER2
por: Olmedo, Maria Eugenia, et al.
Publicado: (2022)

Recent progress of chemotherapy and biomarkers for gastroesophageal cancer
por: Maeda, Osamu, et al.
Publicado: (2019)

Combination therapy with aromatase inhibitors: the next era of breast cancer treatment?
por: Leary, A, et al.
Publicado: (2006)

Adaptive radiation therapy of breast cancer by repeated imaging during irradiation
por: Sager, Omer, et al.
Publicado: (2020)

RC0639: phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancer
por: Moreno-Aspitia, Alvaro, et al.
Publicado: (2013)

Cost-effectiveness of adjuvant paclitaxel and trastuzumab for early-stage node-negative, HER2-positive breast cancer
por: Hajjar, Ali, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_i5ccgvn6lfn8h8864r8n3l8l1p